CD14 and Miyoshi myopathy: Moreover, since the monocytic subset CD14+CD16+ shares both pro-osteoclastogenic and angiogenic properties and increased in MM patients compared to patients with asymptomatic disease [24,25], we analyzed the possible correlation between BM CX3CL1 levels and CD14+CD16+ cells.